Clinical Trials in Houston

Showing 7121-7140 of 17,885 trials

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

NCT05066165

This study will be conducted to evaluate the safety, tolerability, cellular kinetics (CK), activity, and pharmacodynamics (PD) of NTLA-5001 in participants with Acute Myeloid Leukemia (AML).

Acute Myeloid Leukemia

Intellia Therapeutics6 participantsStarted Dec 2021

Los Angeles, California, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 3< 1 mile

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281

This study looks at the safety and effectiveness of VIR-7831 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either VIR-7831 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H2.

COVID-19

National Institute of Allergy and Infectious Diseases (NIAID)367 participantsStarted Dec 2020

Tucson, Arizona, United States • Tucson, Arizona, United States • Fresno, California, United States +102 more locations

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Find Trials by Condition in Houston

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas

Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

A Study of TAK-994 in Adults With Narcolepsy

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Medibio DDA Confirmatory Performance Study

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation